Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
CALL
United States Natural Gas Fund
UNG
$489M
| $34M | 0.01% |
447,775
-129,975
| -22% | -$13.4M |
|
1302
PUT
KKR & Co
KKR
$103B
| $34M | 0.01% |
734,300
+246,400
| +51% | +$12.9M |
|
1303
PUT
Bilibili
BILI
$7.14B
| $33.9M | 0.01% |
1,326,000
-1,268,200
| -49% | -$30.5M |
|
1304
CALL
AstraZeneca
AZN
$244B
| $33.9M | 0.01% |
256,654
-138,300
| -35% | -$18.1M |
|
1305
CALL
Cencora
COR
$59.2B
| $33.9M | 0.01% |
239,600
+59,500
| +33% | +$9.1M |
|
1306
PUT
Teva Pharmaceuticals
TEVA
$42.6B
| $33.9M | 0.01% |
4,507,900
+1,315,400
| +41% | +$11.5M |
|
1307
Xylem
XYL
$28.1B
| $33.9M | 0.01% |
433,161
+300,433
| +226% | +$24.8M |
|
1308
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.8B
| $33.8M | 0.01% |
422,871
+412,029
| +3,800% | +$33.6M |
|
1309
PUT
PENN Entertainment
PENN
$2.53B
| $33.8M | 0.01% |
1,111,684
-234,562
| -17% | -$7.92M |
|
1310
PUT
Aramark
ARMK
$16.1B
| $33.7M | 0.01% |
1,525,578
+1,349,406
| +766% | +$33.3M |
|
|
SIVB
1311
PUT
DELISTED
SVB Financial Group
SIVB
| $33.7M | 0.01% |
85,400
-75,400
| -47% | -$35.5M |
|
1312
Allstate
ALL
$64.7B
| $33.7M | 0.01% |
266,063
-465,493
| -64% | -$61M |
|
1313
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.58B
| $33.7M | 0.01% |
986,554
+510,537
| +107% | +$15.9M |
|
|
IMGO
1314
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $33.7M | 0.01% |
2,517,041
+18,620
| +0.7% | +$296K |
|
1315
CALL
XPO
XPO
$24.7B
| $33.7M | 0.01% |
1,176,754
+433,541
| +58% | +$13.8M |
|
1316
PUT
Monster Beverage
MNST
$91.4B
| $33.6M | 0.01% |
1,452,000
+973,200
| +203% | +$21.2M |
|
1317
CALL
Celsius Holdings
CELH
$7.28B
| $33.6M | 0.01% |
1,546,500
+440,400
| +40% | +$8.49M |
|
1318
CALL
Kohl's
KSS
$2.22B
| $33.6M | 0.01% |
942,400
-493,200
| -34% | -$24.2M |
|
1319
PUT
Intercontinental Exchange
ICE
$87.2B
| $33.6M | 0.01% |
357,500
+252,700
| +241% | +$27M |
|
|
XIFR
1320
XPLR Infrastructure LP
XIFR
$1.08B
| $33.5M | 0.01% |
452,305
+144,168
| +47% | +$10.3M |
|
1321
Kinross Gold
KGC
$31.9B
| $33.5M | 0.01% |
9,368,607
+7,642,542
| +443% | +$37M |
|
1322
IPG Photonics
IPGP
$3.57B
| $33.5M | 0.01% |
356,176
+291,436
| +450% | +$28.8M |
|
1323
Nike
NKE
$61.2B
| $33.5M | 0.01% |
327,714
-138,992
| -30% | -$16.4M |
|
1324
UDR
UDR
$12B
| $33.4M | 0.01% |
726,009
+685,797
| +1,705% | +$34.6M |
|
1325
C.H. Robinson
CHRW
$17.1B
| $33.4M | 0.01% |
329,713
-1,179,321
| -78% | -$123M |
|
Similar funds
Citadel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
- Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.